CIK 0001631574 · Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-03 | Moran Kyle Chief Financial Officer | Sale 10b5-1 | −15,630 | $6.17 | $96K | 33,921 |
| 2024-02-05 | Francis Chris See Remarks | Grant or award · Share Option (right to buy) | +286,400 | 286,400 | ||
| 2024-02-05 | BOLNO PAUL President and CEO | Grant or award · Share Option (right to buy) | +1,008,600 | 1,008,600 | ||
| 2024-02-05 | Moran Kyle Chief Financial Officer | Grant or award · Share Option (right to buy) | +371,500 | 371,500 | ||
| 2024-02-05 | Vargeese Chandra See Remarks | Grant or award · Share Option (right to buy) | +361,700 | 361,700 | ||
| 2023-12-11 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,000,000 | $5.00 | $5.0M | 18,202,009 |
| 2023-12-11 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,000,000 | $5.00 | $5.0M | 19,202,009 |
| 2023-12-07 | GSK plc 10% owner | Purchase | +3,300,000 | $5.00 | $16.5M | 13,983,761 |
| 2023-08-23 | Moran Kyle Chief Financial Officer | Sale 10b5-1 | −37,062 | $4.75 | $176K | 46,120 |
| 2023-08-07 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Share Option (Right to Buy) | +45,000 | 45,000 | ||
| 2023-08-07 | Tan Aik Na Director | Grant or award · Share Option (right to buy) | +45,000 | 45,000 | ||
| 2023-08-07 | TAKANASHI KEN Director | Grant or award · Share Option (right to buy) | +45,000 | 45,000 | ||
| 2023-08-07 | Wagner Heidi L Director | Grant or award · Share Option (right to buy) | +45,000 | 45,000 | ||
| 2023-08-07 | CORRIGAN MARK Director | Grant or award · Share Option (right to buy) | +45,000 | 45,000 | ||
| 2023-08-07 | Rawcliffe Adrian Director | Grant or award · Share Option (right to buy) | +45,000 | 45,000 | ||
| 2023-08-07 | HENRY CHRISTIAN O Director | Grant or award · Share Option (right to buy) | +45,000 | 45,000 | ||
| 2023-08-07 | Verdine Gregory L. Director | Grant or award · Share Option (right to buy) | +45,000 | 45,000 | ||
| 2023-02-17 | Vargeese Chandra See Remarks | Grant or award · Share Option (right to buy) | +295,400 | 295,400 | ||
| 2023-02-17 | BOLNO PAUL President and CEO | Grant or award · Share Option (right to buy) | +771,000 | 771,000 | ||
| 2023-02-17 | Francis Chris See Remarks | Grant or award · Share Option (right to buy) | +244,700 | 244,700 |
Page 12 of 13 · 255 trades